The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 18, 2026

Mar. 18, 2026

VIVUS vahvistaa QSIVA®-kapselien alennetun hinnan voimassaolon nyt Pohjoismaissa ja Puolassa

GlobeNewswire

Mar. 18, 2026

VIVUS bekräftar att prissänkning för QSIVA® nu har trätt i kraft i Norden och Polen

GlobeNewswire

Mar. 18, 2026

VIVUS bekräftar att prissänkning för QSIVA® nu har trätt i kraft i Norden och Polen

GlobeNewswire

Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire

Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire

Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire

Mar. 18, 2026

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

GlobeNewswire

Mar. 18, 2026

AIMイムノテック、アンプリジェンとチェックポイント阻害剤を併用する新規がん治療法の、日本における特許の最終承認を発表

GlobeNewswire

Mar. 18, 2026

RenovoRx Announces $10 Million at Market Private Placement

GlobeNewswire

Mar. 18, 2026

Namib Minerals Announces Date of Full Year 2025 Results and Business Update Call

GlobeNewswire

Mar. 18, 2026

Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study

GlobeNewswire

Mar. 18, 2026

Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform

GlobeNewswire

Mar. 18, 2026

Viral Vector Manufacturing (VVMF) enters into licensing agreement with OXB, gaining access to the OXB AAV and LV viral vector platforms

GlobeNewswire

Mar. 18, 2026

Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting

GlobeNewswire

Mar. 18, 2026

InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting

GlobeNewswire

Mar. 18, 2026

Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026

GlobeNewswire

Mar. 18, 2026

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026

GlobeNewswire

Mar. 18, 2026

Tecnoglass Announces First Quarter 2026 Dividend

GlobeNewswire

Mar. 18, 2026

Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson’s Disease Treated for 28 Days

GlobeNewswire

Mar. 18, 2026

Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform

GlobeNewswire